EV/EBITDA
-10.00
-0.25-2.56%
Wed, 27 Nov 2024 22:07:25 GMT
Summary:
Keros Therapeutics EV/EBITDA is currently -10.00, with a fall of -0.25 (-2.56%) during the most recent trading day. Over the past year, it has dropped by -5.55 (-124.72%). KROS EV/EBITDA is now -169.54% below its all-time high of -3.71.KROS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -2.6% |
| 1 m1 month | +0.8% |
| 3 m3 months | -35.5% |
| 6 m6 months | -24.7% |
| ytdytd | -60.5% |
| 1 y1 year | -124.7% |
| 5 y5 years | - |
KROS EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -8.72 | -14.7% | -12.10 | +17.4% |
| 3 m | 3 months | -7.31 | -36.8% | -12.10 | +17.4% |
| 6 m | 6 months | -6.28 | -59.2% | -12.10 | +17.4% |
| 1 y | 1 year | -3.71 | -169.5% | -14.58 | +31.4% |
| 3 y | 3 years | -3.71 | -169.5% | -21.38 | +53.2% |
| 5 y | 5 years | -3.71 | -169.5% | -47.80 | +79.1% |
| alltime | all time | -3.71 | -169.5% | -47.80 | +79.1% |
Keros Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -10.00(+60.5%) |
| 2023 | -6.23(-38.7%) |
| Date | Value |
|---|---|
| 2022 | -10.16(-51.2%) |
| 2021 | -20.83(-31.3%) |
| 2020 | -30.30 |
FAQ
- What is Keros Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Keros Therapeutics?
- What is KROS EV/EBITDA year-to-date change?
- What is Keros Therapeutics EV/EBITDA year-on-year change?
What is Keros Therapeutics EV/EBITDA?
The current EV/EBITDA of KROS is -10.00
What is the all time high EV/EBITDA for Keros Therapeutics?
Keros Therapeutics all-time high EV/EBITDA is -3.71
What is KROS EV/EBITDA year-to-date change?
Keros Therapeutics EV/EBITDA has changed by -3.77 (-60.51%) since the beginning of the year
What is Keros Therapeutics EV/EBITDA year-on-year change?
Over the past year, KROS EV/EBITDA has changed by -5.55 (-124.72%)